BIOMAT Database Logo BIOMAT Database Logo

Short-term effects of beta-adrenoceptor blocking drugs on plasma lipoproteins in normal men: is there a case? 1986

B Fagher, and M Monti, and H Liedholm

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082

Related Publications

B Fagher, and M Monti, and H Liedholm
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
December 1985, Clinical science (London, England : 1979),
B Fagher, and M Monti, and H Liedholm
Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins.
July 1981, British medical journal (Clinical research ed.),
B Fagher, and M Monti, and H Liedholm
Effects of adrenoceptor-blocking drugs on plasma lipoprotein concentrations.
September 1987, The American journal of cardiology,
B Fagher, and M Monti, and H Liedholm
Beta-adrenoceptor blocking drugs.
October 1977, The Practitioner,
B Fagher, and M Monti, and H Liedholm
Effects of beta 1-adrenoceptor agonism on plasma renin activity in normal men.
November 1983, British journal of clinical pharmacology,
B Fagher, and M Monti, and H Liedholm
The beta-adrenoceptor blocking drugs.
January 1982, International journal of cardiology,
B Fagher, and M Monti, and H Liedholm
Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
October 1980, British journal of clinical pharmacology,
B Fagher, and M Monti, and H Liedholm
Beta-adrenoceptor blocking drugs in therapy.
July 1986, Quarterly medical review,
B Fagher, and M Monti, and H Liedholm
Beta-adrenoceptor blocking drugs in hypertension.
January 1979, Annual review of pharmacology and toxicology,
B Fagher, and M Monti, and H Liedholm
Beta adrenoceptor blocking drugs in hypertension.
January 1978, Clinical and investigative medicine. Medecine clinique et experimentale,
Copied contents to your clipboard!